Corvus Pharmaceuticals, Inc. (CRVS) Operating Lease, Liability USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Corvus Pharmaceuticals, Inc. quarterly Operating Lease, Liability history and growth rate from 2019 to 2024.
  • Corvus Pharmaceuticals, Inc. Operating Lease, Liability for the quarter ending March 31, 2024 was $1.04 M.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $1.04 M Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $1.37 M Dec 31, 2023 10-Q 2024-05-07
Q3 2022 $2.87 M -$1.02 M -26.1% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $3.13 M +$1.35 M +75.7% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $3.39 M +$1.34 M +65.5% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $3.65 M +$1.34 M +57.9% Dec 31, 2021 10-Q 2022-11-03
Q3 2021 $3.89 M +$1.35 M +53.1% Sep 30, 2021 10-Q 2021-11-01
Q2 2021 $1.78 M -$976 K -35.4% Jun 30, 2021 10-Q 2021-08-02
Q1 2021 $2.05 M -$927 K -31.1% Mar 31, 2021 10-Q 2021-04-29
Q4 2020 $2.31 M -$878 K -27.5% Dec 31, 2020 10-K 2022-03-10
Q3 2020 $2.54 M -$850 K -25.1% Sep 30, 2020 10-Q 2020-10-29
Q2 2020 $2.76 M -$820 K -22.9% Jun 30, 2020 10-Q 2020-07-30
Q1 2020 $2.98 M -$792 K -21% Mar 31, 2020 10-Q 2020-04-30
Q4 2019 $3.19 M Dec 31, 2019 10-K 2021-03-25
Q3 2019 $3.39 M Sep 30, 2019 10-Q 2019-10-30
Q2 2019 $3.58 M Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $3.77 M Mar 31, 2019 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.